Adding a Medicine to the WHO Model List of Essential Medicines

被引：13

作者：

Kishore, S. P. ^{[1
]}

Herbstman, B. J. ^{[1
]}

机构：

[1] Weill Cornell Med Coll, New York, NY USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2009年 / 85卷 / 03期

关键词：

CORONARY-HEART-DISEASE; DEVELOPING-WORLD; CARDIOVASCULAR-DISEASE; TOTAL CHOLESTEROL; METAANALYSIS; MORTALITY; STATINS; STROKE;

D O I：

10.1038/clpt.2008.258

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Although the concept of essential medicines is not new, the processes that lead to placement of these medicines on the World Health Organization Model List of Essential Medicines are not well understood. here, we describe the process by which we added a class of drugs, statins, to the Model List to help combat the growing global epidemic of cardiovascular disease.

引用

页码：237 / 239

页数：3

共 50 条

[21] ESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines
Cortese, Samuele
Coghill, David
Fegert, Joerg M.
Mattingly, Gregory W.
Rohde, Luis A.
Wong, Ian C. K.
Faraone, Stephen V.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2024, 33 (05) : 1605 - 1608
[22] Appropriate use of essential medicines in the elderly: a comparison of the WHO essential medicines list and PIM criteria
Xin Ma
Xuxu Yin
Meng Li
Yanwen Wang
Hongxia Xin
Wei Liu
European Journal of Clinical Pharmacology, 2021, 77 : 509 - 516
[23] Appropriate use of essential medicines in the elderly: a comparison of the WHO essential medicines list and PIM criteria
Ma, Xin
Yin, Xuxu
Li, Meng
Wang, Yanwen
Xin, Hongxia
Liu, Wei
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (04) : 509 - 516
[24] A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
Naicker, Ian
Suleman, Fatima
Perumal-Pillay, Velisha Ann
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2022, 15 (01)
[25] A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
Ian Naicker
Fatima Suleman
Velisha Ann Perumal-Pillay
Journal of Pharmaceutical Policy and Practice, 15
[26] Medicines not recommended for inclusion in the who essential medicines list: a retrospective observational study
Costa, Enrico
Del Grosso, Vittorio
Cappello, Bernadette
Genazzani, Armando A.
Huttner, Benedikt
Leufkens, Hubert G. M.
Magrini, Nicola
Nonino, Francesco
Wirtz, Veronika J.
van den Ham, Hendrika A.
Moja, Lorenzo
FRONTIERS IN MEDICINE, 2025, 12
[27] Comparative Analysis of ADR on China's National Essential Medicines List (2015 Edition) and WHO Model List of Essential Medicines (19th Edition)
Zheng, Fangfang
Chen, Hongdou
Chen, Yanfang
Ye, Lu
Wu, Huanhuan
BIOMED RESEARCH INTERNATIONAL, 2018, 2018
[28] Back to the 'essence' of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
Eniu, Alexandru
Torode, Julie
Magrini, Nicola
Bricalli, Gracemarie
ESMO OPEN, 2016, 1 (02)
[29] National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis
Peacocke, Elizabeth F.
Myhreid, Sonja L.
Foss, Hakan Safaralilo
Gopinathan, Unni
PLOS MEDICINE, 2022, 19 (03)
[30] Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines
Twagirumukiza, Marc
Annemans, Lieven
Kips, Jan G.
Bienvenu, Emile
Van Bortel, Luc M.
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 (03) : 350 - 361

← 1 2 3 4 5 →